Biogen | BIIB - Ebit





Ebit Perubahan Tanggal
AbbVie USD 6.72B 1.99B 2026-06
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
ALKERMES USD -65.93M 17.65M 2026-06
Amgen USD 4.61B 777M 2026-06
Bayer EUR 755M 2.77B 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD -707.47M 1.41B 2026-09
Merck USD 7.33B 6.49B 2026-09
Moderna USD -815M 573M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Pfizer USD -180M 5.16B 2026-06
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sanofi EUR 1.12B 811M 2026-06
Sanofi EUR 2.18B 1.56B 2026-03
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06